Founded in 1935 by Doctor Camille Bru, UPSA (Union de Pharmacologie Scientifique Appliquée) has embodied French pharmaceutical excellence for almost a century. The brand's history began with a revolutionary idea: effervescent galenics, inspired by the effect of carbonated drinks on digestion. Thus was born Normogastryl®, UPSA's first effervescent medicine, marking the start of a medical success story.
With rapid expansion under the impetus of its son, Doctor Jean Bru, UPSA was able to innovate by developing advanced galenic formulas such as effervescent aspirin (1960) and effervescent paracetamol (1972). The construction of production sites in Agen, and the adoption of a unique vertical manufacturing process, enable UPSA today to meet patients' needs with unrivalled pharmaceutical quality.
A major player inself-medication, UPSA offers a complete range of medicines to relieve pain, fevers, digestive disorders, ENT symptoms and sleep disorders. Backed by 90 years of expertise, the laboratory continues to innovate and adapt to new public health requirements.
Its production site in Agen is today a veritable technological hub, where each effervescent tablet is designed with remarkable scientific precision. With over 1,600 committed employees, UPSA guarantees products that meet the highest quality standards and are available in pharmacies and online.
UPSA is committed to providing accessible and effective healthcare solutions through research and development, guaranteeing products that meet consumers' needs. The company has succeeded in combining tradition and modernity, while remaining true to its historic commitment: to make life easier for patients thanks to easy-to-use, safe and effective medicines.
UPSA designs and markets healthcare solutions covering a broad spectrum of needs:
Phytovex UPSA: relieves throat irritation and helps thin nasal secretions.
UPSA is also committed to local manufacturing and social responsibility. In 2024, the brand was honored at the Salon du Made in France and the Palais de l'Elysée, illustrating its commitment toFrench excellence.
UPSA places environmental responsibility at the heart of its concerns. The company has implemented a series of eco-responsible measures, including the reduction of industrial waste, the optimization of manufacturing processes and the use of recycled materials in its packaging. The Agen production site is ISO 14001 certified, guaranteeing efficient environmental management that respects natural resources.
UPSA also participates in humanitarian actions through donations of medicines and public health awareness campaigns. The company works with NGOs to make its products accessible in disadvantaged regions, thus actively contributing to the fight against health inequalities.
Every year, UPSA invests in research and development in order to offer ever more effective medicines tailored to patients' needs. In particular, the company is working on innovative galenic forms to enhance the bioavailability of active ingredients, while improving theuser experience through formulations that are more pleasant and easier to administer.
Innovation also involves eco-designed packaging, to reduce environmental impact while guaranteeing optimal product preservation. UPSA strives to optimize its production processes to reduce its carbon footprint, thus contributing to a more responsible pharmaceutical industry.
With its decades of innovation, UPSA has won the trust of healthcare professionals and patients alike. Its burgeoning expertise, local roots and diversified offering make it the reference choice for the relief of pain, ENT disorders, digestive problems and sleep disorders. Choosing UPSA means opting for accessible, effective and safe healthcare.
